Why the study?
Does transcatheter aortic valve replacement with the ACURATE neo2 platform improve short-term performance compared to Evolut PRO/PRO+ devices?
Does transcatheter aortic valve replacement with the ACURATE neo2 platform improve short-term performance compared to Evolut PRO/PRO+ devices?
Answers are grounded in this paper and cite their sources.
The ACURATE neo2 platform demonstrates similar short-term performance to Evolut PRO/PRO+ devices for transcatheter aortic valve replacement in this retrospective analysis.
This retrospective analysis reports a similar short-term performance of the ACURATE neo2 platform compared with the new-generation Evolut PRO/PRO+ devices. Randomised studies are needed to confirm our exploratory findings.
No takes yet. Share an insight, caveat, or question.
Baggio et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: